Differential distribution of muscle and skin sympathetic nerve activity in patients with end-stage renal disease
Authors:
- 1 December 2008
- journal article
- research article
- Published by American Physiological Society in Journal of Applied Physiology
- Vol. 105 (6) , 1873-1876
Abstract
End-stage renal disease (ESRD) is characterized by resting sympathetic overactivity. Baseline muscle sympathetic nerve activity (MSNA), which is governed by baroreflexes and chemoreflexes, is elevated in ESRD. Whether resting skin sympathetic nerve activity (SSNA), which is independent from baroreflex and chemoreflex control, is also elevated has never been reported in renal failure. The purpose of this study was to determine whether sympathetic overactivity of ESRD is generalized to include the skin distribution. We measured sympathetic nerve activity to both muscle and skin using microneurography in eight ESRD patients and eight controls. MSNA was significantly (P = 0.025) greater in ESRD (37.3 ± 3.6 bursts/min) when compared with controls (23.1 ± 4.4 bursts/min). However, SSNA was not elevated in ESRD (ESRD vs. controls, 17.6 ± 2.2 vs. 16.1 ± 1.7 bustst/min, P = 0.61). Similar results were obtained when MSNA was quantified as bursts per 100 heartbeats. We report the novel finding that although sympathetic activity directed to muscle is significantly elevated, activity directed to skin is not elevated in ESRD. The differential distribution of sympathetic outflow to the muscle vs. skin in ESRD is similar to the pattern seen in other disease states characterized by sympathetic overactivity such as heart failure and obesity.Keywords
This publication has 31 references indexed in Scilit:
- Tonic chemoreflex activation contributes to the elevated muscle sympathetic nerve activity in patients with chronic renal failureJournal Of Hypertension, 2007
- Microneurography as a tool in clinical neurophysiology to investigate peripheral neural traffic in humansClinical Neurophysiology, 2006
- Moxonidine Normalizes Sympathetic Hyperactivity in Patients with Eprosartan-Treated Chronic Renal FailureJournal of the American Society of Nephrology, 2004
- Analysis of the Relationship between Norepinephrine and Asymmetric Dimethyl Arginine Levels among Patients with End-Stage Renal DiseaseJournal of the American Society of Nephrology, 2004
- Sympathetic Activation in Obese Normotensive SubjectsHypertension, 1995
- Effects of heart failure on baroreflex control of sympathetic neural activityThe American Journal of Cardiology, 1992
- Effect of dialysis and renal transplantation on autonomic dysfunction in chronic renal failureKidney International, 1991
- Intrarenal Adenosine Produces Hypertension by Activating the Sympathetic Nervous System via the Renal Nerves In the DogJournal Of Hypertension, 1984
- Baroreceptor Activity in Normotensive and Hypertensive Uremic PatientsCirculation, 1973
- Manoeuvres Affecting Sympathetic Outflow in Human Muscle NervesActa Physiologica Scandinavica, 1972